FindTrial
Sign In

The Optimal Concentration of Remifentanil for the i-gel Insertion in Simulated Difficult Airway Patients

The Optimal Concentration of Remifentanil for the i-gel Insertion in Simulated Difficult Airway Patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0000924
Enrollment
47
Registered
2013-11-14
Start date
2013-06-03
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Hanyang University Guri Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: We considered 47 patients, ASA physical status grade I or II, aged 18-70years who were scheduled to undergo elective surgery, for inclusion in the study.

Exclusion criteria

Exclusion criteria: Patients with a body mass index (BMI) greater than 35 kgm-2, those who were to undergo emergency operations and those expected to have difficult intubations were excluded. We defined potentially difficult intubation was defined as the presence of any of: Mallampati class greater than III; mouth opening of less than 2.5 cm; thyromental distance of less than 6.0 cm; or past history of difficult tracheal intubation.

Design outcomes

Primary

MeasureTime frame
The remifentnail effect-site concentration—

Secondary

MeasureTime frame
the existence of compications (sore throat, tooth injury)—

Countries

Korea, Republic of

Contacts

Public ContactSang Yun Cho

Hanyang University Guri Hospital

chosy@hanyang.ac.kr+82-31-560-2390

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026